Compounds > spirogermanium
Page last updated: 2024-08-23

spirogermanium and Disease Models, Animal

spirogermanium has been researched along with Disease Models, Animal in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biegel, JA; Boggs, SS; Schwartz, GN1
Kimler, BF1
Oz, HS; Retsema, J; Tanowitz, HB; Wasserman, S; Weiss, LM; Wittner, M1
Evans, RG; Kimler, BF; Martin, DF; Morantz, RA; Vats, TS1

Other Studies

4 other study(ies) available for spirogermanium and Disease Models, Animal

ArticleYear
A model to study drug effects on lymphoma and normal cell populations using the AKR/J mouse.
    Leukemia research, 1982, Volume: 6, Issue:2

    Topics: Animals; Carmustine; Cell Line; Disease Models, Animal; Germanium; Karyotyping; Leukemia, Experimental; Lymphoma; Mice; Mice, Inbred AKR; Neoplasm Transplantation; Organometallic Compounds; Spiro Compounds

1982
The 9L rat brain tumor model for pre-clinical investigation of radiation-chemotherapy interactions.
    Journal of neuro-oncology, 1994, Volume: 20, Issue:2

    Topics: Animals; Antineoplastic Agents; Aziridines; Benzoquinones; Bleomycin; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease Models, Animal; Dose-Response Relationship, Radiation; Gliosarcoma; Male; Organometallic Compounds; Rats; Rats, Inbred F344; Spiro Compounds; Vincristine

1994
Efficacy of azithromycin for treating Babesia microti infection in the hamster model.
    The Journal of infectious diseases, 1993, Volume: 168, Issue:5

    Topics: Animals; Antimalarials; Azithromycin; Babesiosis; Ciprofloxacin; Clindamycin; Cricetinae; Disease Models, Animal; Drug Therapy, Combination; Mesocricetus; Organometallic Compounds; Quinine; Spiro Compounds; Survival Analysis

1993
Effect of spirogermanium and radiation therapy on the 9L rat brain tumor model.
    NCI monographs : a publication of the National Cancer Institute, 1988, Issue:6

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Organometallic Compounds; Radiotherapy Dosage; Rats; Rats, Inbred F344; Spiro Compounds

1988